Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria

Depression leads to a significant economic and financial burden, which determines the need for implementation of screening programs involving community pharmacists. The aim of this study was to screen patients with chronic conditions for depressive symptoms and to assess their current quality of lif...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yoanna Vutova, Maria Kamusheva, Desislava Ignatova, Petya Milushewa
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2021
Materias:	depression quality of life chronic diseases bulgaria screening program Biotechnology TP248.13-248.65
Acceso en línea:	https://doaj.org/article/5b625542dbc642248f5e5db4be0adff9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5b625542dbc642248f5e5db4be0adff9
record_format	dspace
spelling	oai:doaj.org-article:5b625542dbc642248f5e5db4be0adff92021-11-11T14:23:41ZScreening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria1310-28181314-353010.1080/13102818.2021.1980108https://doaj.org/article/5b625542dbc642248f5e5db4be0adff92021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/13102818.2021.1980108https://doaj.org/toc/1310-2818https://doaj.org/toc/1314-3530Depression leads to a significant economic and financial burden, which determines the need for implementation of screening programs involving community pharmacists. The aim of this study was to screen patients with chronic conditions for depressive symptoms and to assess their current quality of life at community pharmacies in Sofia Province, Bulgaria. A pilot prospective anonymous survey among patients with chronic diseases was conducted. Questionnaires were used: Patient Health Questionnaire-9 (PHQ-9), EQ-5D-5L and a specially designed questions list. The data were analyzed statistically using MedCalc software version 16.4.1. A total of 119 chronically ill patients were screened for depression by community pharmacists for the period March 2020–August 2020 during and after the first wave of the COVID-19 pandemic. Women (59.7%) and patients over 60 years of age (> 50%) predominated. Most patients had only one disease (47.2%), with the most common diseases being cardiovascular, followed by other endocrine and metabolic diseases. Of the respondents, 64.9% showed depressive symptoms, of which 50.9% were mild and 14% severe. The median pharmacotherapy cost was higher for patients with depression compared to patients who do not show depressive symptoms: BGN 28.50 compared to BGN 14.77. The obtained results suggest that the implementation of an early depression screening service in the community pharmacy settings would provide easy and timely access of patients to adequate mental care. The service would lead to improved quality of pharmaceutical care in Bulgaria and increased range of services that pharmacists offer in community pharmacy practice.Yoanna VutovaMaria KamushevaDesislava IgnatovaPetya MilushewaTaylor & Francis Grouparticledepressionquality of lifechronic diseasesbulgariascreening programBiotechnologyTP248.13-248.65ENBiotechnology & Biotechnological Equipment, Vol 35, Iss 1, Pp 1393-1400 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	depression quality of life chronic diseases bulgaria screening program Biotechnology TP248.13-248.65
spellingShingle	depression quality of life chronic diseases bulgaria screening program Biotechnology TP248.13-248.65 Yoanna Vutova Maria Kamusheva Desislava Ignatova Petya Milushewa Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria
description	Depression leads to a significant economic and financial burden, which determines the need for implementation of screening programs involving community pharmacists. The aim of this study was to screen patients with chronic conditions for depressive symptoms and to assess their current quality of life at community pharmacies in Sofia Province, Bulgaria. A pilot prospective anonymous survey among patients with chronic diseases was conducted. Questionnaires were used: Patient Health Questionnaire-9 (PHQ-9), EQ-5D-5L and a specially designed questions list. The data were analyzed statistically using MedCalc software version 16.4.1. A total of 119 chronically ill patients were screened for depression by community pharmacists for the period March 2020–August 2020 during and after the first wave of the COVID-19 pandemic. Women (59.7%) and patients over 60 years of age (> 50%) predominated. Most patients had only one disease (47.2%), with the most common diseases being cardiovascular, followed by other endocrine and metabolic diseases. Of the respondents, 64.9% showed depressive symptoms, of which 50.9% were mild and 14% severe. The median pharmacotherapy cost was higher for patients with depression compared to patients who do not show depressive symptoms: BGN 28.50 compared to BGN 14.77. The obtained results suggest that the implementation of an early depression screening service in the community pharmacy settings would provide easy and timely access of patients to adequate mental care. The service would lead to improved quality of pharmaceutical care in Bulgaria and increased range of services that pharmacists offer in community pharmacy practice.
format	article
author	Yoanna Vutova Maria Kamusheva Desislava Ignatova Petya Milushewa
author_facet	Yoanna Vutova Maria Kamusheva Desislava Ignatova Petya Milushewa
author_sort	Yoanna Vutova
title	Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria
title_short	Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria
title_full	Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria
title_fullStr	Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria
title_full_unstemmed	Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria
title_sort	screening for depression among chronically ill patients in community pharmacy settings: a pilot study in bulgaria
publisher	Taylor & Francis Group
publishDate	2021
url	https://doaj.org/article/5b625542dbc642248f5e5db4be0adff9
work_keys_str_mv	AT yoannavutova screeningfordepressionamongchronicallyillpatientsincommunitypharmacysettingsapilotstudyinbulgaria AT mariakamusheva screeningfordepressionamongchronicallyillpatientsincommunitypharmacysettingsapilotstudyinbulgaria AT desislavaignatova screeningfordepressionamongchronicallyillpatientsincommunitypharmacysettingsapilotstudyinbulgaria AT petyamilushewa screeningfordepressionamongchronicallyillpatientsincommunitypharmacysettingsapilotstudyinbulgaria
_version_	1718439038827888640

Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria

Ejemplares similares